Trials / Completed
CompletedNCT01364363
Unrelated Donor Stem Cell Transplantation
Allogeneic Hematopoietic Progenitor Cell Transplantation From Unrelated Donors
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Scripps Health · Academic / Other
- Sex
- All
- Age
- 18 Years – 69 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to provide an opportunity for patients with malignancies or bone marrow failure states who lack a suitable sibling donor to undergo allogeneic hematopoietic progenitor cell transplantation using cells from unrelated individuals or cord blood registries.
Detailed description
same
Conditions
- Severe Aplastic Anemia
- Paroxysmal Nocturnal Hemoglobinuria
- Acute Myelogenous Leukemia
- Acute Lymphoblastic Leukemia
- Myelodysplastic Syndromes
- Myeloproliferative Syndromes
- Chronic Myelogenous Leukemia
- Hodgkin's Lymphoma
- Non-Hodgkin's Lymphoma
- Multiple Myeloma
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Large Granulocytic Leukemia
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Allogeneic transplantation | Allogeneic transplantation with matched unrelated donors |
Timeline
- Start date
- 2005-03-01
- Primary completion
- 2015-07-01
- Completion
- 2015-07-01
- First posted
- 2011-06-02
- Last updated
- 2022-11-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01364363. Inclusion in this directory is not an endorsement.